JOURTHON® Unveils Innovative Brain Health Softgel for Mental Vitality

HelthJin Biotech has launched a new supplement aimed at enhancing cognitive function, known as JOURTHON® Brain Health Softgel. Unveiled on October 9, 2025, in New York, this product targets memory lapses, concentration issues, and mental fatigue, which have increasingly affected individuals across various age groups, including professionals and parents.

The JOURTHON® supplement is designed to support memory, focus, and long-term neuron protection through a carefully formulated blend of ingredients recognized as Generally Recognized As Safe (GRAS) by the U.S. FDA. This assurance provides consumers with confidence in both the safety and efficacy of the product.

Advanced Ingredients for Enhanced Brain Function

Unlike many single-ingredient supplements, JOURTHON® features a unique “Golden Brain Essence” blend comprising three clinically studied compounds: L-Ergothioneine (L-ET), Pyrroloquinoline Quinone (PQQ), and Alpha-GPC. Each ingredient plays a distinct role in promoting brain health.

L-Ergothioneine serves as a powerful antioxidant that protects neurons from oxidative stress. Research indicates that L-ET, which can cross the blood-brain barrier, works in tandem with vitamin E to mitigate the risk of neurodegenerative diseases. By clearing harmful free radicals and reducing metal ion stress, L-ET helps maintain the brain’s structure and function over time.

Meanwhile, Pyrroloquinoline Quinone (PQQ) supports mitochondrial health and enhances brain resilience. Animal studies have shown that PQQ can reverse memory issues linked to prolonged oxidative stress and improve performance on cognitive tests. Additionally, it stimulates the production of nerve growth factor, which fosters new connections between neurons, thereby enhancing cognitive performance and cellular energy.

Alpha-GPC acts as a bioavailable precursor to acetylcholine, the neurotransmitter essential for memory and focus. Clinical trials indicate that participants who consumed Alpha-GPC before cognitive challenges performed significantly better on attention tasks, demonstrating its potential for immediate cognitive enhancement. This fast-acting capability makes Alpha-GPC a critical component of JOURTHON®, addressing both immediate and long-term cognitive needs.

Comprehensive Benefits and Safety Standards

The JOURTHON® Brain Health Softgel is produced under stringent quality standards, ensuring reliability and consistency. Each softgel undergoes rigorous quality checks, with its safety supported by trusted certifications. The formulation not only aids cognitive health but also contributes to immune support and helps prevent nutrient deficiencies.

Key features of the JOURTHON® supplement include:

– **Improving Brain Health**: Designed to assist older adults in retaining memories and staying mentally sharp, addressing common issues like forgetfulness.
– **Protecting the Nervous System**: Supports the health of brain nerves and safeguards neurons against damage, potentially reducing long-term cognitive decline.
– **Enhancing Cognitive Performance**: Aims to improve focus and decision-making for busy professionals, enabling better task management.
– **Supporting Emotional Balance**: Contributes to emotional stability by reducing frustration and mood swings, promoting a sense of calm and resilience.

JOURTHON® combines activation, improvement, and stability to nurture overall brain health. This innovative supplement aims to empower individuals from all walks of life to maintain mental vitality and mitigate age-related cognitive decline.

The brand, guided by the philosophy of “Innovative-Tech Formulations, Safeguarding Body and Mind,” seeks to simplify healthy living, providing science-backed nutrition for both the body and mind.

For more information, interested individuals can visit the official JOURTHON® website or contact media representative Rainey at [email protected].